(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) slid 8.53% to $3.17 at 13:33 EST on Thursday, after five sequential sessions in a row of losses. NASDAQ is dropping 0.45% to $11,313.13, following the last session’s downward trend. This seems, so far, a somewhat bearish trend trading session today.
TherapeuticsMD’s last close was $3.46, 25.82% higher than its 52-week high of $2.75.
Today’s last reported volume for TherapeuticsMD is 637406 which is 197.22% above its average volume of 214455.
TherapeuticsMD’s sales growth is 33.7% for the ongoing quarter and 29.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 16.7% and 40%, respectively.
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 11.61%, a negative 4.61%, and a positive 6.62%, respectively.
TherapeuticsMD’s highest amplitude of average volatility was 11.61% (last week), 5.46% (last month), and 6.62% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
TherapeuticsMD’s stock is considered to be oversold (<=20).
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $3.17 at 13:33 EST, way above its 52-week high of $2.75.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s worth is way above its 50-day moving average of $0.66 and way above its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).